Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium-dependent phosphate transporter type IIb (NaPi-IIb, SLC34A2) and sodium-dependent phosphate transporters 1 and 2 (PiT-1/SLC20A1, PiT-2/SLC20A2) are membrane proteins responsible for the majority of active phosphate transport in the intestine (NaPi-IIb) and for cellular phosphate uptake in multiple tissues (PiT-1 and PiT-2). They play essential roles in phosphate absorption, systemic phosphate balance, and are implicated in several hereditary and acquired metabolic and bone diseases[1][2][4]. NaPi-IIb is primarily found in the small intestine and lungs, whereas PiT-1 and PiT-2 have broad tissue distribution, serving both housekeeping and specialized regulatory functions in phosphate metabolism.
Competitive inhibition (for available sodium-phosphate transporter inhibitors)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-dependent phosphate transporter type IIb (NaPi-IIb), Sodium-dependent phosphate transporter 1 (PiT-1), and Sodium-dependent phosphate transporter 2 (PiT-2) (NaPi-IIb, PiT-1, PiT-2).